(Q47216290)

11 January 2018

title

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma (English)

1 reference

11 January 2018

4

Gad Rennert

1 reference

11 January 2018

author name string

Ofer Lavie

1

1 reference

11 January 2018

Gila Hornreich

2

1 reference

11 January 2018

Alon Ben-Arie

3

1 reference

11 January 2018

Yoram Cohen

5

1 reference

11 January 2018

Rehuven Keidar

6

1 reference

11 January 2018

Shlomi Sagi

7

1 reference

11 January 2018

Efrat Levy Lahad

8

1 reference

11 January 2018

Ron Auslander

9

1 reference

11 January 2018

Uzi Beller

10

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

11 January 2018

published in

Gynecologic Oncology

1 reference

11 January 2018

volume

92

1 reference

11 January 2018

issue

2

1 reference

11 January 2018

page(s)

521-524

1 reference

11 January 2018

Stage I serous papillary carcinoma of the endometrium

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Uterine papillary serous carcinoma. A clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

A genetic epidemiological study of carcinoma of the fallopian tube

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

BRCA1 germline mutations in women with uterine serous papillary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Risk of Endometrial Carcinoma Associated with BRCA Mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

Specific keynote: hereditary ovarian cancer: what we know

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.009

10.1016/J.YGYNO.2003.11.009

7 January 2021

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

14766242

1 reference

11 January 2018